46 related articles for article (PubMed ID: 19548658)
1. The Effects of Jabara Juice on the Intestinal Permeation of Fexofenadine.
Han H; Akiyoshi T; Morita T; Tsuchitani T; Nabeta M; Yajima K; Imaoka A; Ohtani H
Biol Pharm Bull; 2023; 46(12):1745-1752. PubMed ID: 38044133
[TBL] [Abstract][Full Text] [Related]
2. The influence of rhein on the absorption of rehmaionoside D: In vivo, in situ, in vitro, and in silico studies.
Yang H; Zhai B; Wang M; Fan Y; Wang J; Cheng J; Zou J; Zhang X; Shi Y; Guo D; Tang Z
J Ethnopharmacol; 2022 Jan; 282():114650. PubMed ID: 34536515
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
4. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
Elsby R; Martin P; Surry D; Sharma P; Fenner K
Drug Metab Dispos; 2016 Mar; 44(3):398-408. PubMed ID: 26700956
[TBL] [Abstract][Full Text] [Related]
5. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
8. Impact of transporters in oral absorption: a case study of in vitro and in vivo organic anion absorption.
Gram LK; Rist GM; Steffansen B
Mol Pharm; 2009; 6(5):1457-65. PubMed ID: 19548658
[TBL] [Abstract][Full Text] [Related]
9. [The transporters of intestinal tract and their study methods].
Liu ZH; Liu KX
Yao Xue Xue Bao; 2011 Apr; 46(4):370-6. PubMed ID: 21751488
[TBL] [Abstract][Full Text] [Related]
10. [Role of transporters in hepatic drug disposition].
Gao CY; Chen XY; Zhong DF
Yao Xue Xue Bao; 2012 May; 47(5):565-72. PubMed ID: 22811997
[TBL] [Abstract][Full Text] [Related]
11. Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.
Zakeri-Milani P; Valizadeh H
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):859-71. PubMed ID: 24708201
[TBL] [Abstract][Full Text] [Related]
12. [A review on regulation of drug transporters during inflammation].
Zeng H; Bi HC; Huang M
Yao Xue Xue Bao; 2011 Jul; 46(7):773-9. PubMed ID: 22010345
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
